The Food and Drug Administration said it cleared the Eli Lilly drug for adults and adolescent patients with mild-to-moderate cases of COVID-19.

Job burnout and stressful work environments are contributing to a growing shortage of pharmacists in the state.

Pharmacists are the latest members of the medical field in demand to fill a rising number of job openings.

As the COVID-19 pandemic lingers Indiana pharmacies face a shortage of pharmacists.

Congress is debating a Democratic proposal, H.R.3, that would allow the federal government to negotiate prescription drug prices in an effort to lower costs.

The new price -- starting Jan. 1 -- will be about $80 per vial and comparable to how much a vial of Lilly's brand name Humalog insulin cost in 2008.

Starting Jan. 1, Lilly will drop the cost of its Insulin Lispro Injection -- the generic of its insulin Humalog -- by 40 percent, saving about $50 per vial.

A state law signed by Gov. Eric Holcomb this year requires cities and counties that want to pursue their own legal action to "opt out" of the attorney general's lawsuits by June 30.

A pharmaceutical automation company will locate its global headquarters in Indianapolis with the promise of hundreds of high paying jobs over the next two years.

Eli Lilly's new COVID-19 treatment helped the drugmakers fourth-quarter profit surge even though U.S. regulators approved its use late in the quarter.